Skip to main content
Akshat Jain, MD, Hematology, Loma Linda, CA

Akshat Jain MD MPH

Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias


Faculty Clinical Medicine and Pediatrics . Loma Linda University School of Medicine California

Join to View Full Profile
  • Loma linda Childrens Hospital250 East Caroline StreetLoma Linda, CA 92354

  • Phone+1 909-651-1910

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Akshat Jain is a pediatric hematologist and oncologist based in Loma Linda, CA. He specializes in various pediatric hematology subspecialties, including anemia, coagulation disorders, hematologic oncology, and platelet disorders.

    Accomplished physician-scientist and clinical trial leader specializing in pediatric hematology/oncology, bleeding disorders, and gene therapy. Renowned for spearheading innovative clinical research, directing comprehensive treatment programs, and advancing curative therapies for inherited blood disorders. Recognized nationally and internationally for leadership in clinical trials, translational research, and policy development to improve outcomes for children and adults with hematologic diseases.

    Key Strengths:
    - Clinical Trials Leadership: Loma Linda University Clinical Trials Leader for outstanding contributions to the design, execution, and oversight of multicenter clinical trials in bleeding disorders, hemoglobinopathies, and gene therapy.
    - Program Development: Medical Director for Hemophilia Treatment Center and NASCC Certified Comprehensive Sickle Cell Center of Excellence at Loma Linda University, overseeing clinical research operations and patient recruitment for innovative therapies after starting both these programs from scratch.
    - Translational Research:Chair of the Experimental Therapeutics Research Task Force, driving bench-to-bedside research and facilitating early-phase clinical trials for novel therapeutics in pediatric hematology/oncology.

Education & Training

  • Hofstra University
    Hofstra UniversityMPh, 2015
  • Other
    OtherClass of 2005
  • Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical Center
    Zucker School of Medicine at Hofstra/Northwell at Cohen Children's Medical CenterFellowship, Pediatric Hematology/Oncology

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2016 - 2026
  • NY State Medical License
    NY State Medical License 2013 - 2016
  • ME State Medical License
    ME State Medical License Active through 2013
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Physician of the Year 2025 Hemophilia Foundation of Southern California, 2025
  • International Guest Faculty , Chair UNICEF ,Asia, 2025
  • Healing Hands Award Loma Linda University Health, 2025
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Reproductive health in young people with sickle cell disease  
    Akshat Jain, APHA, 10/6/2024
  • Oxidant Health in sickle cell disease  
    Jain A., Pediatric Hematology Oncology Journal, 9/8/2018
  • Non Alcoholic Fatty Liver Disease in Kabuki Syndrome  
    Jain Akshat, See Mary, Journal of Pediatrics and Neonatal Care, 1/1/2015
  • Join now to see all

Abstracts/Posters

  • Reduced Intensity Conditioning in Transplants for Patients with Sickle Cell Disease: Effect of "Late"
    Alemtuzumab; Akshat Jain, Indira Sahdev, Joel Brochstein, 2015 International society of Bone Marrow Transplantation (ISBMT) Tandem meeting, 1/1/2015
  • Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinoapthies in Children
    Allison A King, Nancy Bunin, Indira Sahdev, Joel A Brochstein, Alistair Abraham, Jacqueline Dioguardi,, Naynesh R. Kamani, Akshat Jain, Eric Hanson, Lisa Murray and Sh..., American Society of Hematology December (ASH), 1/1/2014
  • Prevalence of Lead poisoning in children 0-16 yrs. of age in Urban North Western India
    Jain A, New York Epidemiology Forum, 1/1/2014
  • Join now to see all

Lectures

  • Advances in Global Hematology 
    Joseph B Martin Conference Center at Harvard Medical School - 8/2/2015
  • Hofstra School of Health Science & Human Services 
    Boston Children's Hospital, Joseph B Martin Conference Center at Harvard Medical School - 1/2/2015
  • Emergencies in Pediatric Hematology and Oncology 
    New York Medical College - 1/1/2015
  • Join now to see all

Other

  • Global health Inequalities for children - "The Killer Gap 
    Jain A, Hofstra University Newsletter
    1/1/2013
  • Focus on Pediatrics in Manhattan - Metropolitan Hospital 
    Jain A, American Academy of Pediatrics , dist2newsletter
    1/1/2010

Authored Content

  • ASH AwardApril 2024

Press Mentions

  • California Center Is First in State to Offer Hympavzi for Hemophilia B
    California Center Is First in State to Offer Hympavzi for Hemophilia BFebruary 25th, 2025
  • LLUH Becomes First in California to Offer Immunotherapy for Hemophilia B Patients
    LLUH Becomes First in California to Offer Immunotherapy for Hemophilia B PatientsFebruary 20th, 2025
  • Navigating Patient Transitions Following the Withdrawal of Oxbryta
    Navigating Patient Transitions Following the Withdrawal of OxbrytaNovember 21st, 2024
  • Join now to see all

Grant Support

  • HRSA-23-112 Sickle Cell Disease and Maternal Health Research Collaborative for Minority-Serving InstitutionsHealth Resources and Services Administration (HRSA)2023–2028
  • NASCC Electronic Health Record Pediatric to adult transition GrantNational Association of Sickle Cell Centers2023–2025
  • American Thrombosis and Hemostasis Network Data GRANTA.T.H.N.2022–2025

Research History

  • Clinical TrialistPhase 1 - Phase 4 Clinical Trials as Principal Investigator including various roles as Global P.I., End Point Adjudication Committee , Steering committee for clinical trials .2017 - 2025

Professional Memberships

Other Languages

  • Spanish

Industry Relationships

  • Advisory, BayerAdvisory board for hemophilia treatment strategies2018 - 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: